Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
The Department of Justice and its Drug Enforcement Administration are resolutely committed to enforcing the law and ensuring the safety of American citizens from the perilous threat posed by illegal drugs. Among these substances, fentanyl stands out as the most dangerous, acting as a synthetic opioid that has become the leading cause of death for individuals aged 18 to 45 in the country. Adding to this dire situation, the rising availability of addictive methamphetamine compounds the challenge.
Mexican drug cartels have developed a sophisticated global supply chain, acquiring precursor chemicals from nations like China and manufacturing fentanyl and methamphetamine in clandestine labs located in Mexico. These illicit drugs are then smuggled across the border into the United States, creating a grave impact on American communities. Recent CDC data reveals a staggering toll, with approximately 82,000 Americans lost to drug overdoses last year, nearly 49,000 of which were linked to fentanyl, and over 30,000 associated with psychostimulants, including methamphetamine.
Despite signs of a decrease in overdose deaths in recent months, the ongoing threat of fentanyl remains. This potent substance often contaminates other drugs and counterfeit pills, posing an ever-present risk. Additionally, cartels are producing methamphetamine pills that mimic the appearance of popular drugs like Adderall or MDMA, which are frequently misused by young adults. The intersection of fentanyl and methamphetamine illustrates the cartels’ blatant disregard for human life.
The DEA has a clear mission to confront this crisis directly. With unparalleled expertise in gathering and analyzing intelligence, the DEA has committed itself to prosecuting those responsible for the distribution of these toxic drugs, including all substances related to fentanyl, to the fullest extent allowed by law.
Under the leadership of President Donald J. Trump, the DOJ and DEA have launched Operation Take Back America, an assertive initiative targeting the criminal organizations that traffic fentanyl and other synthetic opioids. This unprecedented action represents a significant effort to reclaim communities and save American lives.
Since the operation’s initiation on January 20, DEA efforts have resulted in the seizure of over 44 million fentanyl pills and approximately 4,500 pounds of fentanyl powder. These seizures equate to over 180 million lethal doses, alongside more than 68,000 pounds of methamphetamine. Each confiscation translates to a life saved, with each arrest removing a trafficker from circulation. Each operation sends a critical message: the United States will not accept this assault on its citizens.
Our approach is systematic, lawful, and steadfast. The DEA operates within a robust framework of legal authority aimed at tackling the entire spectrum of drug-related offenses. Title 21 empowers federal prosecution of drug manufacturers and distributors, while RICO statutes facilitate the dismantling of these criminal enterprises. Furthermore, asset forfeiture laws strip traffickers of their financial resources, and international extradition agreements ensure that no trafficker operating from outside the United States is out of reach of American justice. Each of these elements works in harmony with U.S. Attorneys’ Offices, upholding constitutional protections and federal evidentiary standards.
Highlighted cases of recent fentanyl and methamphetamine seizures across the nation illuminate the urgent necessity to persist in targeting the drug supply chain comprehensively.
Our strategy extends beyond mere arrests and seizures. Recently, President Trump enacted the HALT Fentanyl Act, which serves to strengthen penalties for fentanyl distributors and close loopholes that allow chemists to engineer new synthetic compounds to evade prosecution.
Under his guidance, the administration has revitalized interagency collaboration, with the DOJ and DEA working in tandem with U.S. Customs and Border Protection, Homeland Security Investigations, the Federal Bureau of Investigation, and the Bureau of Alcohol, Tobacco, Firearms and Explosives. This unity from interdiction to indictment ensures cohesive case development. Additionally, the president has empowered the use of diplomatic pressure, economic sanctions, and trade penalties to hold accountable the foreign entities responsible for supplying chemicals that fuel this crisis.
The DOJ has placed high priority on enhancing penalties for trafficking offenses that result in serious bodily injury or death. This approach encompasses not only the traffickers but also those who facilitate the trade, such as money launderers, logistical supporters, and intermediaries between cartel members and chemical suppliers. If you profit from this lethal trade, expect to face the full weight of American law.
In a groundbreaking move, President Trump has designated eight major cartels as Foreign Terrorist Organizations. This designation enables the deployment of new tools against traffickers, allowing charges of material support to terrorism, which can carry sentences of up to life in prison.
As reminders of the human cost of this epidemic, the walls of DEA Headquarters in Arlington are adorned with images of those lost to fentanyl. These faces resonate deeply, fueling our determination to eliminate these cartels and safeguard our communities.
The message from President Trump is crystal clear: a nation’s sovereignty relies upon secure borders and safe neighborhoods. The era of unchecked drug trafficking across our borders is over. The federal government is shifting from a defensive to an offensive posture.
The American populace is entitled to a justice system that defends families against the violence of drug trafficking and the heartbreak of overdose deaths. The DEA and DOJ are delivering this justice.
We will remain relentless in our pursuit to dismantle cartels, disrupt their supply chains, and ultimately end this epidemic. This is a pivotal battle for the future of our country, and we are resolute in our commitment to prevail.
Robert Murphy serves as the acting administrator of the U.S. Drug Enforcement Administration, overseeing a dedicated team of nearly 9,000 public servants devoted to protecting Americans from the threats posed by drug trafficking.
